Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2

Cardiovascular Research

Volumn 58, Issue 1, 2003, Pages 170-177

  Ohmori, Tsukasa ^a   Yatomi, Yutaka ^a   Osada, Makoto ^a   Kazama, Fuminori ^a   Takafuta, Toshiro ^a   Ikeda, Hitoshi ^b   Ozaki, Yukio ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Lipid metabolism; Receptor; Signal transduction; Smooth muscle; Vasoconstriction dilation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; BACTERIAL ENZYME; CELL SURFACE RECEPTOR; EXOENZYME C3; JTE 013; PERTUSSIS TOXIN; PHOSPHATASE; PHOSPHATE; PYRIDINE DERIVATIVE; RHO FACTOR; SEROTONIN; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL SURFACE; CHO CELL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY CONSTRICTION; DEPHOSPHORYLATION; HUMAN; HUMAN CELL; LIPID DEGRADATION; LIPID METABOLISM; MEDIATOR RELEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THROMBOCYTE;

ACUTE-PHASE PROTEINS; AMIDES; BLOOD PLATELETS; CELLS, CULTURED; CORONARY VESSELS; HUMANS; LYSOPHOSPHOLIPIDS; MUSCLE, SMOOTH, VASCULAR; PYRAZOLES; PYRIDINES; SIGNAL TRANSDUCTION; SPHINGOSINE; VASOCONSTRICTION;

EID: 0037401276     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00260-8     Document Type: Article

References (28)

1. Spiegel S., Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. J Biol Chem. 277:2002;25851-25854.
2. Kluk M.J., Hla T. Signaling of sphingosine-1-phosphate via the S1P/EDG family of G-protein-coupled receptors. Biochim Biophys Acta. 1582:2002;72-80.
3. Ghosh T.K., Bian J., Gill D.L. Intracellular calcium release mediated by sphingosine derivatives generated in cells. Science. 248:1990;1653-1656.
4. Zhang H., Desai N.N., Olivera A., et al. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J Cell Biol. 114:1991;155-167.
5. Cuvillier O., Pirianov G., Kleuser B., et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 381:1996;800-803.
6. Hla T., Lee M.J., Ancellin N., et al. Sphingosine-1-phosphate: extracellular mediator or intracellular second messenger? Biochem Pharmacol. 58:1999;201-207.
7. Levade T., Auge N., Veldman R.J., et al. Sphingolipid mediators in cardiovascular cell biology and pathology. Circ Res. 89:2001;957-968.
8. Yatomi Y., Ruan F., Hakomori S., Igarashi Y. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood. 86:1995;193-202.
9. Yatomi Y., Yamamura S., Ruan F., Igarashi Y. Sphingosine-1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid. J Biol Chem. 272:1997;5291-5297.
10. Yatomi Y., Igarashi Y., Yang L., et al. Sphingosine-1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem (Tokyo). 121:1997;969-973.
11. Sugiyama A., Yatomi Y., Ozaki Y., Hashimoto K. Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart. Cardiovasc Res. 46:2000;119-125.
12. Morii N., Narumiya S. Preparation of native and recombinant Clostridium botulinum C3 ADP-ribosyltransferase and identification of Rho proteins by ADP-ribosylation. Methods Enzymol. 256:1995;196-206.
13. Uehata M., Ishizaki T., Satoh H., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 389:1997;990-994.
14. Hisano N., Yatomi Y., Satoh K., et al. Induction and suppression of endothelial cell apoptosis by sphingolipids: a possible in vitro model for cell-cell interactions between platelets and endothelial cells. Blood. 93:1999;4293-4299.
15. Ren X.D., Kiosses W.B., Schwartz M.A. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18:1999;578-585.
16. Ancellin N., Hla T. Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J Biol Chem. 274:1999;18997-19002.
17. Takai Y., Sasaki T., Matozaki T. Small GTP-binding proteins. Physiol Rev. 81:2001;153-208.
18. Kaibuchi K. Regulation of cytoskeleton and cell adhesion by Rho targets. Prog Mol Subcell Biol. 22:1999;23-38.
19. Mandala S.M. Sphingosine-1-phosphate phosphatases. Prostaglandins Other Lipid Mediat. 64:2001;143-156.
20. 2+-independent phosphatidic acid phosphatase. J Biol Chem. 272:1997;24572-24578.
21. Waggoner D.W., Xu J., Singh I., et al. Structural organization of mammalian lipid phosphate phosphatases: implications for signal transduction. Biochim Biophys Acta. 1439:1999;299-316.
22. 2+-insensitive contraction and paxillin tyrosine phosphorylation in smooth muscle. Am J Physiol. 279:2000;C308-318.
23. Kandabashi T., Shimokawa H., Miyata K., et al. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1β Circulation. 101:2000;1319-1323.
24. Utsunomiya T., Satoh S., Ikegaki I., et al. Antianginal effects of hydroxyfasudil, a Rho-kinase inhibitor, in a canine model of effort angina. Br J Pharmacol. 134:2001;1724-1730.
25. 12 families of heterotrimeric G proteins. J Biol Chem. 274:1999;27351-27358.
26. Liu C.H., Thangada S., Lee M.J., et al. Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. Mol Biol Cell. 10:1999;1179-1190.
27. Pilquil C., Ling Z.C., Singh I., et al. Co-ordinate regulation of growth factor receptors and lipid phosphate phosphatase-1 controls cell activation by exogenous lysophosphatidate. Biochem Soc Trans. 29:2001;825-830.
28. Mandala S., Hajdu R., Bergstrom J., et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 296:2002;346-349.